2025/04/29

We are proud to announce the closure of an oversubscribed Pre-Series A funding round, backed by leading investors including HEMEX, Zürcher Kantonalbank, Excellis, EFI Lake Geneva Ventures, and Club degli Investitori.

With this support—alongside ongoing funding from Horizon Europe and Innosuisse—Annaida is accelerating the development of its pioneering Micro-MRS technology, bringing new possibilities to science and medicine.

PRESS RELEASE

2024/12/31

Our patent N.2019800771876 for a ‘Miniaturized Magnetic Resonance Device’ has been granted in China too, following granting in EU and Japan.

Patent details

2024/04/01

The HyperCell project will focus on the optimization, integration and validation of NVISION’s Quantum-Based Platform, which Enhances NMR spectrometers’ sensitivity to metabolites via hyperpolarization, enabling real-time monitoring of intracellular metabolic activity, with ANNAIDA’s Embryospin Sensor Technology Tailored for microscale NMR.

*Grant agreement ID: 101158959

2024/01/29

Our core patent N.3857247 for a ‘Miniaturized Magnetic Resonance Device’ has been granted in Japan too, following recent granting in EU.

2024/01/10

Annaida awarded the highly competitive Innosuisse Startup Innovation Project by Innosuisse. The grant, worth up to CHF 1.2M will support development and validation of Annaida’s device for non-invasive metabolic fingerprinting of embryos and more!

2023/09/22

Our core patent N.3857247 for a ‘Miniaturized Magnetic Resonance Device’ has been granted in Europe.

2023/09/04

For the fourth consecutive year ANNAIDA is selected among the Top100 Swiss startups. 

2021/02/01

Annaida awarded the highly competitive EIC-SME INSTRUMENT PHASE 2 Grant* by the EU. The grant supports innovative SMEs in developing novel solutions with a strong social impact. Annaida will use the funds to accelerate product development and safety validation, bringing its breakthrough device closer to market.

*Grant number 959600

2020/04/09

We are proud to finally announce the closure of an oversubscribed financing round of CHF 1M. A big thank you goes to our investors: HEMEX AG, Fongit Seed Invest, Zürcher Kantonalbank, Business Angels Switzerland, Privilège Ventures, Venture Kick and an angel. Even in these complicated times Switzerland continues to believe and invest in innovation.

2020/03/11

Annaida has been selected in the among the Top16 by de Vigier Stiftung for the 2020 W.A. We are honored to be participating to this prestigious award!